Benefits and risks of using laparoscopic ultrasonography versus intraoperative cholangiography during laparoscopic cholecystectomy for gallstone disease

Edebo A, Andersson J, Gustavsson J, JivegÄrd L, Khan J, Ribokas D, Svanberg T, Wallerstedt SM
Record ID 32018011309
Authors' objectives: In patients undergoing laparoscopic cholecystectomy for gallstone disease, how does the use of intraoperative laparoscopic ultrasonography compare to the use of intraoperative cholangiography regarding the risk of mortality, bile duct injury, retained gallstone, conversion to open cholecystectomy, procedural failure, surgical complications, other complications, and operation time (with time for diagnostic method reported separately)?
Authors' results and conclusions: For the comparison LUS versus IOC to visualise the biliary tract during laparoscopic cholecystectomy, this HTA shows that no conclusions can be drawn regarding the critical and important outcomes mortality, bile duct injury, retained gallstone, and procedural failure (all very low certainty of evidence). LUS may be associated with fewer conversions to open cholecystectomy (low certainty evidence) and is probably associated with a shorter imaging time (moderate certainty evidence), but data are lacking regarding potential effects on the entire operation time. Given the sparsity of evidence combined with promising results, further well-designed studies are considered highly warranted.
Project Status: Completed
Year Published: 2024
English language abstract: An English language summary is available
Publication Type: Full HTA
MeSH Terms
  • Cholecystectomy, Laparoscopic
  • Cholelithiasis
  • Ultrasonography, Interventional
  • Ultrasonography
  • Gallstones
Organisation Name: The Regional Health Technology Assessment Centre
Contact Address: The Regional Health Technology Assessment Centre, Region Vastra Gotaland, HTA-centrum, Roda Straket 8, Sahlgrenska Universitetssjukhuset, 413 45 GOTHENBORG, Sweden
Contact Name:
Contact Email:
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.